Literature DB >> 23216612

Crosstalk between T lymphocytes and dendritic cells.

Claire Hivroz1, Karine Chemin, Marie Tourret, Armelle Bohineust.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) with the unique property of inducing priming and differentiation of naïve CD4+ and CD8+ T cells into helper and cytotoxic effectors. Their efficiency is due to their unique ability to process antigen, express costimulatory molecules, secrete cytokines, and migrate to tissues or lymphoid organs to prime T cells. DCs also play an important role in T-cell peripheral tolerance. There is ample evidence that the DC ability to present antigens is regulated by CD4+ helper T cells. Indeed, interactions between surface receptors and ligands expressed respectively by T cells and DCs, as well as T-cell-derived cytokines modify DC functions. This T-cell-induced modification of DCs has been called "education" or "licensing." This intimate crosstalk between DCs and T lymphocytes is key in establishing appropriate adaptive immune responses. It requires cognate interactions between T lymphocytes and DCs, which are organized in time and space by structures called immunological synapses. Here we discuss the particular aspects of immunological synapses formed between T cells and DCs and the role these organized interactions have in T-cell-DC crosstalk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216612     DOI: 10.1615/critrevimmunol.v32.i2.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  41 in total

1.  Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.

Authors:  Q Jiao; C Liu; W Li; W Li; F Fang; Q Qian; X Zhang
Journal:  Clin Exp Immunol       Date:  2017-03-12       Impact factor: 4.330

Review 2.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

3.  Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor.

Authors:  D M Elizondo; T E Andargie; K M Marshall; A M Zariwala; M W Lipscomb
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

4.  Impaired cell migration and structural defects in myeloid cells overexpressing miR-30b and miR-142-3p.

Authors:  Araceli Valverde; Salvador Nares; Afsar Raza Naqvi
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-09-24       Impact factor: 4.490

5.  T Cell Reprogramming Against Cancer.

Authors:  Samuel G Katz; Peter M Rabinovich
Journal:  Methods Mol Biol       Date:  2020

6.  Human Primary Immune Cells Exhibit Distinct Mechanical Properties that Are Modified by Inflammation.

Authors:  Nathalie Bufi; Michael Saitakis; Stéphanie Dogniaux; Oscar Buschinger; Armelle Bohineust; Alain Richert; Mathieu Maurin; Claire Hivroz; Atef Asnacios
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

7.  Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.

Authors:  Bin Su; Alexandre Lederle; Géraldine Laumond; Camille Ducloy; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

Review 8.  Dendritic cells and B cells: unexpected partners in Th2 development.

Authors:  Beatriz León; André Ballesteros-Tato; Frances E Lund
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

9.  Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.

Authors:  Emmanuelle Godefroy; Yunfeng Liu; Patricia Shi; W Beau Mitchell; Devin Cohen; Stella T Chou; Deepa Manwani; Karina Yazdanbakhsh
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

Review 10.  The current status of checkpoint inhibitors in metastatic bladder cancer.

Authors:  Omar Fahmy; Mohd Ghani Khairul-Asri; Arnulf Stenzl; Georgios Gakis
Journal:  Clin Exp Metastasis       Date:  2016-07-05       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.